Biogen to Acquire RayThera in Deal Worth Up to USD 1 Billion to Strengthen Immunology Pipeline
Biogen has agreed to acquire immunology-focused biotech firm RayThera in a deal worth up to USD 1 billion, gaining a portfolio of anti-inflammatory drug candidates and strengthening its pipeline for immune-mediated diseases.
Biopharmaceutical Industry | 20/06/2026 | By News Bureau
The National Institute for Innovation in Manufacturing Biopharmaceuticals (NIIMBL) and the Open Applications Group (OAGi) in the US have jointly unveiled a pioneering set of ontologies designed to enhance data interoperability and analytics capabilities across the biopharmaceutical industry.
Biopharmaceutical Industry | 13/11/2025 | By Dineshwori | 282
We use our own and third party cookies to produce statistical information and show you personalized advertising by analyzing your browsing, according to our COOKIES POLICY. If you continue visiting our Site, you accept its use.
More information: Privacy Policy